Clinical application of pharmacogenetics in gastrointestinal diseases.

about

Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients.Targeted therapy of cancer: new roles for pathologists in colorectal cancer.The role of pharmacogenetics in nonmalignant gastrointestinal diseases.

P2860

Q36089956-BF4C3608-E294-4B1A-B697-9388735A3389 Q37147762-72803793-93B2-4D67-B721-1B96A5E3156E Q37981892-65AF7E7D-9570-4DDB-90C5-F79D5F2B7BB7

P2860

Clinical application of pharmacogenetics in gastrointestinal diseases.

Item

http://www.wikidata.org/entity/Q36613862

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Clinical application of pharmacogenetics in gastrointestinal diseases.

@ast

Clinical application of pharmacogenetics in gastrointestinal diseases.

@en

type

Item

label

Clinical application of pharmacogenetics in gastrointestinal diseases.

@ast

Clinical application of pharmacogenetics in gastrointestinal diseases.

@en

prefLabel

Clinical application of pharmacogenetics in gastrointestinal diseases.

@ast

Clinical application of pharmacogenetics in gastrointestinal diseases.

@en

P1476

Clinical application of pharmacogenetics in gastrointestinal diseases.

@en

P2093

Yuri A Saito

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity.

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole.

P304

1857-1869

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.7.14.1857

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Camilleri

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17020413

http://www.w3.org/2001/XMLSchema#string

Clinical application of pharmacogenetics in gastrointestinal diseases.

about

P2860

P2860

Clinical application of pharmacogenetics in gastrointestinal diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698